Biden’s New War On Cancer to Harness the Technology of MRNA

Region:

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @globalresearch_crg.

***

 

Joe Biden has announced that his administration is re-launching a 2016 initiative to “end cancer as we know it,” by “harnessing science” in a way that’s similar to the way science was harnessed to fight COVID. 

On Feb. 2, the Biden-Harris Administration announced they were “reigniting” the “Cancer Moonshot” to “end cancer as we know it.”

The Cancer Moonshot was originally launched in 2016, with the mission of accelerating the rate of progress against cancer.

On Wednesday, President Joe Biden explained that the initiative’s new ambitious aim is to reduce the rate of cancer by 50% in 25 years.

“We’re going to break down the walls that hold research back,” said Vice President Kamala Harris during the announcement.

According to White House, the Biden Administration plans to launch ARPA-H, or the Advanced Research and Projects Agency for Health,.

“It’s based on DARPA [Defense Advanced Research Projects Agency], mostly everyone in this town knows what DARPA is,” said Biden at the announcement event.

DARPA is a secretive research and development arm of the Pentagon which was involved in Operation Warp Speed and has been funding Moderna’s mRNA technology as far back as 2013.

According to the White House, this new agency plans to model the development of next generation cancer drugs after the development of the COVID vaccines, which they say “demonstrated we can accelerate clinical trials without compromising safety & effectiveness.” 

But VAERS data shows that as of Jan. 21 the COVID vaccines have reportedly caused 121,000 hospitalizations and 22,000 deaths.

“Just as we harnessed science to develop the cutting edge COVID vaccines, we’ll bring a fierce sense of urgency to the fight against cancer,” said President Joe Biden during the announcement event.

The White House also mentioned using mRNA technology in their war against cancer, saying that “scientists are asking” if the mRNA technology, used in the “safe and effective COVID-19 vaccines” could be used to “stop cancer cells when they first appear.”

It’s possible the White House is referring to scientists at Moderna. According to their website, Moderna is applying their mRNA technology to “cancer vaccines” and the emerging field of “immuno-oncology.” 

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @globalresearch_crg. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Jeremy Loffredo is a freelance reporter for The Defender. His investigative reporting has been featured in The Grayzone and Unlimited Hangout. Jeremy formerly produced news programs at RT America.

Featured image is from National Cancer Institute via Unsplash


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


Articles by: Jeremy Loffredo

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]